tiprankstipranks
Trending News
More News >
Incyte Corp (INCY)
NASDAQ:INCY

Incyte (INCY) Similar Stocks

Compare
1,723 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Incyte
$68.46
$13.22B
211.82
8.29%
7 Buy
9 Hold
1 Sell
Moderate Buy
BioMarin Pharmaceutical
$55.00
$10.59B
20.50
-34.64%
13 Buy
5 Hold
0 Sell
Moderate Buy
Exelixis
$40.37
$11.11B
18.48
81.85%
10 Buy
6 Hold
0 Sell
Moderate Buy
United Therapeutics
$290.75
$13.16B
11.60
-8.00%
7 Buy
3 Hold
0 Sell
Moderate Buy
Ascendis Pharma
$176.90
$10.31B
38.37%
14 Buy
0 Hold
0 Sell
Strong Buy
Genmab
$21.16
$13.44B
12.10
-18.71%
4 Buy
2 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INCY
Incyte
68.46
5.24
8.29%
BMRN
BioMarin Pharmaceutical
55.00
-28.78
-34.35%
EXEL
Exelixis
40.37
18.17
81.85%
UTHR
United Therapeutics
290.75
-25.29
-8.00%
ASND
Ascendis Pharma
176.90
49.05
38.37%
GMAB
Genmab
21.16
-4.87
-18.71%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis